The Benefits of the Smart Monitor 2 in Assessing Premature Infants

Published in Respiratory & Sleep on August 28, 2019

Circadiance is featured in the Summer 2019 issue of Neonatal Intensive Care Magazine, starting on page 19. The interview is titled, "The Benefits of the Smart Monitor 2 in Assessing Premature Infants." In this section of the magazine, Neonatal Intensive Care interviews clinicians and healthcare providers about the actual application of specific products and therapies. This interview is with Pam Stading, MPH, RN NE-BC, Patient Care Manager, Cardiopulmonary Services for Children’s Minnesota.

To download a PDF of the article, click here.

The Smart Monitor 2 family of cardiorespiratory event monitors can be used in the hospital, as well as the home, to provide caregivers with an understanding of the physical vulnerabilities of at-risk preterm infants, low birth weight infants, and those infants that have tested positive for opiates. In the clinical setting, Smart Monitor 2 PS (Professional Series) can be used to measure heart rate, respiration, and O2 saturation levels that can be evaluated to aid in step-down or discharge planning and follow-up care. Used as a diagnostic tool, Smart Monitor 2 PS can document central apnea, bradycardia, hypopnea, and other apparent life-threatening events or BRUEs. In the home, Smart Monitor Home Care can alert anxious parents to potential BRUEs and provide clinicians with downloadable data they can access for interpretation and prescribe an appropriate course of care. In addition to monitoring preterm infants, the monitors are cleared for pediatric and adult patients. The Smart Monitor 2 product line is the only FDA approved infant apnea monitor.

To learn more about Smart Monitor, visit our website or email us at [email protected].